A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant boost in the form of a new...

In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival,...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new hope. In a new study published in Cell...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new hope. In a new study published in Cell...

A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach...

Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...

Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...

In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival,...